KLRH1 Activators
Killer cell lectin-like receptor subfamily H, member 1 (KLRH1) activators include chemicals that influence the activation and function of natural killer (NK) cells, where KLRH1 is implicated. Phorbol 12-myristate 13-acetate (PMA) and Bryostatin 1, by activating protein kinase C (PKC), elicit a cascade of intracellular events that bolster NK cell cytotoxicity, which in turn would enhance the functional activity of KLRH1. Similarly, compounds like Ionomycin, Monensin, and Thapsigargin modulate intracellular calcium levels, a crucial element in NK cell signaling, thus indirectly supporting the activation of KLRH1 by promoting NK cell activity.
Other molecules, such as CpG Oligodeoxynucleotides, stimulate toll-like receptor 9 (TLR9), enhancing NK cell-mediated immune responses, which could lead to an upregulated function of KLRH1. The immunomodulatory effects of Lenalidomide and Imiquimod, through their action on T and NK cells, are also likely to enhance KLRH1 activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC). PKC activation enhances the cytotoxic response of natural killer (NK) cells. Since KLRH1 is associated with NK cell activity, PMA can enhance the functional activity of KLRH1 by promoting NK cell cytotoxicity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium, a second messenger in various signaling pathways. Elevated calcium levels in NK cells can therefore enhance the functional activity of KLRH1 by increasing NK cell activation and cytotoxicity. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
As a modulator of PKC, Bryostatin 1 can activate signaling pathways downstream of PKC in NK cells, which may enhance the functional activity of KLRH1 by promoting NK cell cytotoxicity. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Lenalidomide enhances the immune response by costimulating NK cells. This costimulation can enhance the functional activity of KLRH1 on NK cells. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
As a TLR7 agonist, Imiquimod activates NK cells through innate immune pathways, which can enhance the functional activity of KLRH1. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
The biologically active form of vitamin D modulates immune response, including NK cell function. This modulation can enhance the functional activity of KLRH1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol modulates cell survival and apoptosis pathways. This modulation may enhance NK cell cytotoxicity and thus the functional activity of KLRH1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases, leading to enhanced NK cell responses which could enhance the functional activity of KLRH1. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that alters intracellular ion concentrations, affecting NK cell activation and potentially enhancing the functional activity of KLRH1. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts protein transport, which can affect NK cell function and could indirectly enhance the functional activity of KLRH1 by altering the cellular environment. | ||||||